Durability of left bundle branch area pacing

J Cardiovasc Electrophysiol. 2022 Jul;33(7):1529-1536. doi: 10.1111/jce.15545. Epub 2022 May 26.

Abstract

Background: Left bundle branch area pacing (LBBAP) is a form of conduction system pacing. Long-term data on the safety and performance of LBBAP 1 year postdevice implantation has not been well described.

Methods and results: Sixty-five patients (49% females) who received LBBAP for bradycardia indications using the SelectSecure 3830 lead (Medtronic) were retrospectively evaluated. Clinical variables were examined. Lead parameters were obtained at implant and during regular follow-up. Mean age of patients was 75.7 ± 10.1 years with left ventricular ejection fraction 59.8 ± 10.4%. Indications for pacing were atrioventricular block 55%, sinus node dysfunction 19%, tachy-brady syndrome 15%, atrioventricular node ablation 8%, and bail out cardiac resynchronization therapy 3%. Mean baseline QRS measured 120 ± 38 ms, paced QRS duration was 138 ± 22ms. Paced QRS narrowed by 24 ms in those with pre-existing left bundle branch block (BBB), increased by 1 ms in those with pre-existing right BBB, and increased by 42 ms in those with no BBB. LBBAP threshold at implant was 0.521 ± 0.153 V at 0.4 ms, and increased to 0.654 ± 0.186 V at 3 months (+26%), 0.707 ± 0.186 V at 6 months (+36%), and 0.772 ± 0.220 V at 12 months (+48%). Patients with left BBB showed the maximum benefit with QRS narrowing 24 ms. Pacing impedance remained unchanged with no procedure-related complications.

Conclusion: LBBAP is a durable form of conduction system pacing with pacing thresholds remaining relatively stable over 12 months post device implantation. Patients with left BBB display the narrowest paced QRS.

Keywords: conduction system pacing; durability; left bundle branch pacing; physiologic pacing; threshold.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bundle of His*
  • Cardiac Conduction System Disease
  • Cardiac Pacing, Artificial / methods
  • Cardiac Resynchronization Therapy* / adverse effects
  • Cardiac Resynchronization Therapy* / methods
  • Electrocardiography / methods
  • Female
  • Humans
  • Male
  • Retrospective Studies
  • Sick Sinus Syndrome / therapy
  • Stroke Volume
  • Treatment Outcome
  • Ventricular Function, Left